Clinical Trials Update: Feb. 7, 2007
Hot Flashes Parkinson's Disease Endometriosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you have hot flashes that are interfering with your daily life, you may qualify for this clinical study of an investigational medication. Female volunteers may qualify who are generally healthy, are having multiple daily moderate-to-severe hot flashes, and are at least six months beyond the last menstrual period or are surgically sterile.
The research site is in San Diego, Calif.
This study will evaluate the impact of creatine, an investigational drug, in slowing clinical decline in people with Parkinson's disease. You may qualify if you have been diagnosed with Parkinson's within the past five years, have been using medication to treat symptoms of Parkinson's for more than 90 days but less than two years, and have no unstable medical condition.
The research site is in Lexington, Ky.
This study will evaluate an investigational medication for women with endometriosis. Women 18-49 may be included who had endometriosis diagnosed following a laparoscopic visualization within the past seven years, have moderate-to-severe pain associated with endometriosis, and are not pregnant or breastfeeding.
The research site is in Kansas City, Mo.
Copyright 2007 Thomson CenterWatch. All rights reserved.